GENOME & CO
DEAD

Serial Number

79322563

Owner

Genome&Company, Inc.

Filing Date

Sep 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

GENOME & CO Trademark

Serial Number: 79322563

GENOME & CO is a trademark filed by Genome&Company, Inc. on September 3, 2021. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Genome&Company, Inc.

7,8F, 50, Changnyong-daero 256beon-gil
Suwon-si, Gyeonggi-do 16229 , KR

Entity Type: 03

Genome and Company (6 trademarks)

B-dong 8F, 35, Pangyo-ro 255beon-gil,

Entity Type: 99

Trademark Details

Filing Date

September 3, 2021

Registration Date

Not Registered

Goods & Services

Business intermediary services relating to mail order by telecommunications; business intermediary services for the sale and purchase of goods and services; business management services relating to franchising; provision of commercial information from on-line databases; intermediary services relating to the trading of goods and services; import-export agency services; merchandising services for inducing the purchasing public to buy the goods of others; compilation of information into computer databases; management and compilation of computerized databases in the field of science, medicine, pharmacology and clinical pathology; retail services for pharmaceuticals; retail services for cosmetics; retail services for cosmetic utensils; retail services for dietary supplements; retail services of health food supplements for persons with special dietary requirements; retail services for probiotic supplements; retail services for slimming pills; retail services for bioinformatics software; wholesale services of biological preparations for medical purposes; wholesale services of biological preparations for pharmaceutical purposes; wholesale services of biological preparations for cosmetics; wholesale services of biological preparations for food; wholesale services for pharmaceuticals; wholesale services of pharmaceutical preparations and compositions for the treatment or prevention of cancer

Conducting early evaluations in the field of new pharmaceuticals; drug discovery services; consultancy in the field of testing, inspection, research of medical products; scientific research in the fields of medicine/health and pharmacology; services for assessing the efficiency of pharmaceuticals; clinical trials; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; platform as a service; programming of software for drug discovery platforms; constructing an internet platform for drug discovery; cosmetics research; research and development of new products; conducting technical project studies; engineering testing; microbiological testing; biotechnological research relating to industry; biotechnology services; food research; materials testing and evaluation; design services relating to process systems for the biotechnology industry

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 16, 2026 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 18, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jan 26, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 26, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 4, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 15, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 15, 2023 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 26, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 26, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 26, 2023 ABN2
REFUSAL PROCESSED BY IB
Aug 2, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 14, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jul 14, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 26, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jun 25, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 9, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 19, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 14, 2021 REPR